Secondary outcomes
There was no significant difference in the median (95% CI) time-to- hematological recovery (WBC ≥ 4 × 10^9/L and Platelet ≥ 100 × 10^9/L) in the 15 (7 (4.3–9.7)) and 25 mg groups (6 (4.4–7.6) days (Kaplan–Meier survival curves showing cumulative time-to-event for hematological recovery in the two groups. (Hematological recovery defined as both WBC (≥ 4 × 10^9/L) and platelet recovery (≥ 100 × 10^9/L))